• OPEN AN ACCOUNT
Indian Indices
Sensex
82,031.81 -500.38
( -0.61%)
Global Indices
Nasdaq
50,652.56 -976.61
(-1.89%)
Dow Jones
7,328.13 -109.46
(-1.47%)
Hang Seng
59,089.01 228.58
(0.39%)
Nikkei 225
10,703.23 -178.32
(-1.64%)
Forex
USD-INR
93.96 -0.30
(-0.32%)
EUR-INR
103.45 -0.43
(-0.42%)
GBP-INR
123.99 -0.51
(-0.41%)
JPY-INR
0.59 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
18.604918
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
40.12
77.09
EPS(TTM)
Face Value()
Div & Yield %
1.26
10
0
 

Mobavenue launches ResurgeX in US market
Oct 27,2026

Mobavenue AI Tech announced the launch of ResurgeX in the United States. ResurgeX is an AI-powered programmatic demand-side platform (DSP) for retargeting and remarketing, built to help app marketers re-engage existing users, improve conversions and increase customer lifetime value.

Most retargeting tools work from fixed lists and set rules. ResurgeX learns from every campaign and adjusts who it targets, what ads it shows and how much it bids in real time as user behaviour changes. The launch builds on the start of Mobavenue's US operations in July 2026 and brings the Activation layer of its A3 framework, Awareness, Acquisition and Activation, to American advertisers.